Results 261 to 270 of about 717,050 (341)

Effect of varenicline on major adverse liver outcomes in alcohol‐associated liver disease: An exploratory analysis

Alcohol, Clinical and Experimental Research, EarlyView.
This real‐world study assessed whether varenicline improves outcomes in patients with ALD and AUD. Using data from a large electronic health record network, 1278 matched patients were analyzed. Varenicline use was associated with reduced all‐cause mortality and hepatic encephalopathy compared with FDA‐approved AUD therapies (acamprosate or naltrexone),
Pojsakorn Danpanichkul, Yanfang Pang, Donghee Kim, Thanathip Suenghataiphorn, Donghyun Ko, Andrew F. Ibrahim, Vitchapong Prasitsumrit, Kwanjit Duangsonk, Mazen Noureddin, Karn Wijarnpreecha, Suthat Liangpunsakul   +10 more
wiley   +1 more source

Navigating smoking cessation in healthcare: a pilot study of the SMOKE AKAT questionnaire among family medicine residents. [PDF]

Front Public Health
Petričušić I, Marelić M, Ćenan L, Brborović H, Brborović O.   +4 more
europepmc   +1 more source

Internet-based interventions for smoking cessation.

Cochrane Database of Systematic Reviews, 2017
G. Taylor, Michael N Dalili, Monika Semwal, M. Čivljak, A. Sheikh, J. Car   +5 more
semanticscholar   +1 more source

Pharmacological and Mechanistic Interventions for Cognitive Impairment Associated With Schizophrenia: A Review of Registered Clinical Trials

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Schizophrenia is characterized by positive, negative, and cognitive symptoms. Current pharmacological treatments often fail to address cognitive deficits. In this review of clinical trials, we aim to identify studies that explore neurobiological (non‐psychological) strategies to address Cognitive Impairment Associated with ...
Bahareh Peyrovian, Lena Palaniyappan, Theodore T. Kolivakis, Howard C. Margolese   +3 more
wiley   +1 more source

Effect and acceptability of an mHealth smoking cessation intervention 'Stopcoach' combined with smoking cessation counseling for people from multiple levels of socioeconomic position: a multi-methods study. [PDF]

Subst Abuse Treat Prev Policy
de Frel DL, Zijp A, van den Putte B, Troelstra S, Hermsen S, Heemskerk E, Janssen VR, Atsma DE, Chavannes NH, Meijer E.   +9 more
europepmc   +1 more source

Mobile phone-based interventions for smoking cessation.

Cochrane Database of Systematic Reviews, 2016
R. Whittaker, H. McRobbie, C. Bullen, A. Rodgers, Yulong Gu   +4 more
semanticscholar   +1 more source

Risk of Stroke in Patients With Schizophrenia, Bipolar Disorder, and Major Depressive Disorder: A Cohort Study of 183,504 Subjects

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Major psychiatric disorder, including schizophrenia, bipolar disorder, and major depressive disorder, has been individually associated with increased risk of stroke. However, few studies have directly compared the stroke risk across these diagnostic groups within a unified cohort framework while accounting for stroke subtypes and ...
Mao‐Hsuan Huang, Chih‐Ming Cheng, Ju‐Wei Hsu, Ya‐Mei Bai, Tung‐Ping Su, Cheng‐Ta Li, Shih‐Jen Tsai, Yee‐Lam E. Chan, Mu‐Hong Chen   +8 more
wiley   +1 more source

Generalized estimating equations for modeling cluster randomized trial data on smoking cessation among tuberculosis patients. [PDF]

PLoS One
Mahalingam V, Singh R, Santhanakrishnan RK, Bhaskar A, Chinnaiyan P.   +4 more
europepmc   +1 more source

Nicotine receptor partial agonists for smoking cessation.

Cochrane Database of Systematic Reviews, 2016
K. Cahill, Nicola Lindson-Hawley, K. Thomas, T. Fanshawe, T. Lancaster   +4 more
semanticscholar   +1 more source